Journal
SCIENCE
Volume 294, Issue 5548, Pages 1936-1939Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1063564
Keywords
-
Categories
Funding
- NCI NIH HHS [CA52511] Funding Source: Medline
- NIAID NIH HHS [AI 19807, AI50263] Funding Source: Medline
- NIDDK NIH HHS [DK54451] Funding Source: Medline
Ask authors/readers for more resources
The thymus leukemia antigen (TL) is a nonclassical class I molecule, expressed abundantly on intestinal epithelial cells. We show that, in contrast to other major histocompatibility complex (MHC) class I molecules that bind CD8 alpha beta, TL preferentially binds the homotypic form of CD8 alpha (CD8 alpha alpha). Thus, TL tetramers react specifically to CD8 alpha alpha -expressing cells, including most intestinal intraepithelial lymphocytes. Compared with CD8 alpha beta, which recognizes the same MHC as the T cell, receptor (TCR) and thus acts as a TCR coreceptor, high-affinity binding of CD8 alpha alpha to TL modifies responses mediated by TCR recognition of antigen presented by distinct MHC molecules. These findings define a novel mechanism of lymphocyte regulation through CD8 alpha alpha and MHC class I.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available